Context Whether radioactive iodine therapy (RAIT) is necessary for intermediate-risk
papillary thyroid cancer (PTC) after total thyroidectomy is still lacking reliable evidence�…

Background Thyroglobulin antibody (TgAb) has been found to be associated with the
occurrence and development of differentiated thyroid cancer (DTC) for several years, but�…

Context The risk of persistent and recurrent disease in patients with differentiated thyroid
cancer (DTC) is a continuum that ranges from very low to very high, even within the 3�…

Purpose: To systemically investigate the prognostic value of pre-ablation stimulated
thyroglobulin (s-Tg) in children and adolescents with differentiated thyroid cancer. Methods�…

Introduction Differentiated thyroid cancer (DTC) is the most common of endocrine cancers.
Many studies have focused on recurrence-free survival of DTC patients, however, few�…

Background The size of lymph node metastasis (LNM) and pre-ablation stimulated Tg (ps-
Tg) were key predictors of clinical prognosis in differentiated thyroid cancer (DTC) patients�…

Objective Since papillary thyroid cancer (PTC) patients with pre-ablation stimulated
thyroglobulin (s-Tg)< 1 ng/mL generally have a favorable prognosis, is TSH suppression still�…

Background There are no definite recommendations on the optimal time of initiating
radioactive iodine (RAI) therapy for differentiated thyroid cancer (DTC) patients in current�…

Objective It is not clear whether response to initial treatment in papillary thyroid carcinoma
(PTC) patients is best evaluated by measuring thyroglobulin (Tg) in the presence of�…

Background Repeated radioiodine (131I) treatment (RT) are commonly performed in
patients with 131I-avid distant metastatic differentiated thyroid cancer (DM-DTC), but more�…